Literature DB >> 25541124

The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting.

Carla N Holcomb1, Laura A Graham2, Joshua S Richman3, Robert R Rhyne1, Kamal M F Itani4, Thomas M Maddox5, Mary T Hawn6.   

Abstract

BACKGROUND: Recent coronary stent placement and noncardiac surgery contribute to the risk of adverse cardiac events, but the relative contributions of these two factors have not been quantified.
OBJECTIVES: This research was designed to determine the incremental risk of noncardiac surgery on myocardial infarction (MI) and coronary revascularization following coronary stenting.
METHODS: A U.S. retrospective cohort study of patients receiving coronary stents at Veterans Affairs medical centers between 2000 and 2010 was used to match patients undergoing noncardiac surgery within 24 months of stent placement to two patients with stents not undergoing surgery. Patients were matched on stent type and cardiac risk factors present at the time of stent placement. A composite endpoint of MI and/or cardiac revascularization for the 30-day interval post-surgery was calculated. Adjusted risk differences (RD) were compared across time periods following stent implantation, using generalized estimating equations.
RESULTS: We matched 20,590 surgical patients to 41,180 nonsurgical patients. During the 30-day interval following noncardiac surgery, the surgical cohort had higher rates of the composite cardiac endpoint (3.1% vs. 1.9%; RD: 1.3%; 95% confidence interval: 1.0% to 1.5%). The incremental risk of noncardiac surgery adjusted for surgical characteristics ranged from 3.5% immediately following stent implantation to 1% at 6 months, after which it remained stable out to 24 months. Factors associated with a significant reduction in risk following surgery more than 6 months post-stent included elective inpatient procedures (ΔRD: 1.8%; p = 0.01), high-risk surgery (ΔRD: 3.7%; p = 0.01), and drug-eluting stent (DES) (ΔRD: 1.3%; p = 0.01).
CONCLUSIONS: The incremental risk of noncardiac surgery on adverse cardiac events among post-stent patients is highest in the initial 6 months following stent implantation and stabilizes at 1.0% after 6 months. Elective, high-risk, inpatient surgery, and patients with DES may benefit most from delay from a 6-month delay after stent placement.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adverse; coronary stent; post-operative; surgery

Mesh:

Year:  2014        PMID: 25541124     DOI: 10.1016/j.jacc.2014.09.072

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management.

Authors:  Davide Cao; Rishi Chandiramani; Davide Capodanno; Jeffrey S Berger; Matthew A Levin; Mary T Hawn; Dominick J Angiolillo; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2020-08-05       Impact factor: 32.419

2.  3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.

Authors:  Danielle Menosi Gualandro; Pai Ching Yu; Bruno Caramelli; André Coelho Marques; Daniela Calderaro; Luciana Savoy Fornari; Claudio Pinho; Alina Coutinho Rodrigues Feitosa; Carisi Anne Polanczyk; Carlos Eduardo Rochitte; Carlos Jardim; Carolina L Z Vieira; Debora Y M Nakamura; Denise Iezzi; Dirk Schreen; Eduardo Leal Adam; Elbio Antonio D'Amico; Emerson Q de Lima; Emmanuel de Almeida Burdmann; Enrique Indalecio Pachón Mateo; Fabiana Goulart Marcondes Braga; Fabio S Machado; Flavio J de Paula; Gabriel Assis Lopes do Carmo; Gilson Soares Feitosa-Filho; Gustavo Faibischew Prado; Heno Ferreira Lopes; João R C Fernandes; José J G de Lima; Luciana Sacilotto; Luciano Ferreira Drager; Luciano Janussi Vacanti; Luis Eduardo Paim Rohde; Luis F L Prada; Luis Henrique Wolff Gowdak; Marcelo Luiz Campos Vieira; Maristela Camargo Monachini; Milena Frota Macatrão-Costa; Milena Ribeiro Paixão; Mucio Tavares de Oliveira; Patricia Cury; Paula R Villaça; Pedro Silvio Farsky; Rinaldo F Siciliano; Roberto Henrique Heinisch; Rogerio Souza; Sandra F M Gualandro; Tarso Augusto Duenhas Accorsi; Wilson Mathias
Journal:  Arq Bras Cardiol       Date:  2017 Jan-Feb       Impact factor: 2.000

3. 

Authors:  André Arpad Faludi; Maria Cristina de Oliveira Izar; José Francisco Kerr Saraiva; Ana Paula Marte Chacra; Henrique Tria Bianco; Abrahão Afiune; Adriana Bertolami; Alexandre C Pereira; Ana Maria Lottenberg; Andrei C Sposito; Antonio Carlos Palandri Chagas; Antonio Casella; Antônio Felipe Simão; Aristóteles Comte de Alencar; Bruno Caramelli; Carlos Costa Magalhães; Carlos Eduardo Negrão; Carlos Eduardo Dos Santos Ferreira; Carlos Scherr; Claudine Maria Alves Feio; Cristiane Kovacs; Daniel Branco de Araújo; Daniel Magnoni; Daniela Calderaro; Danielle Menosi Gualandro; Edgard Pessoa de Mello; Elizabeth Regina Giunco Alexandre; Emília Inoue Sato; Emilio Hideyuki Moriguchi; Fabiana Hanna Rached; Fábio César Dos Santos; Fernando Henpin Yue Cesena; Francisco Antonio Helfenstein Fonseca; Henrique Andrade Rodrigues da Fonseca; Hermes Toros Xavier; Isabela Cardoso Pimentel Mota; Isabela de Carlos Back Giuliano; Jaqueline Scholz Issa; Jayme Diament; João Bosco Pesquero; José Ernesto Dos Santos; José Rocha Faria; José Xavier de Melo; Juliana Tieko Kato; Kerginaldo Paulo Torres; Marcelo Chiara Bertolami; Marcelo Heitor Vieira Assad; Márcio Hiroshi Miname; Marileia Scartezini; Neusa Assumpta Forti; Otávio Rizzi Coelho; Raul Cavalcante Maranhão; Raul Dias Dos Santos; Renato Jorge Alves; Roberta Lara Cassani; Roberto Tadeu Barcellos Betti; Tales de Carvalho; Tânia Leme da Rocha Martinez; Viviane Zorzanelli Rocha Giraldez; Wilson Salgado
Journal:  Arq Bras Cardiol       Date:  2017-07       Impact factor: 2.000

4.  Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial.

Authors:  Gert Richardt; Mohammad Abdelghani; Abdelhakim Allali; Ralph Toelg; Mohamed Abdellaoui; Florian Krackhardt; Rune Wiseth; Marie-Claude Morice; Samuel Copt; Hans-Peter Stoll; Philip Urban
Journal:  Clin Res Cardiol       Date:  2020-05-21       Impact factor: 5.460

5.  Coronary Angiography and Revascularization Prior to Noncardiac Surgery.

Authors:  Joshua Schulman-Marcus; Raymond A Pashun; Dmitriy N Feldman; Rajesh V Swaminathan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

6.  The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection.

Authors:  Thuy B Tran; David J Worhunsky; David A Spain; Monica M Dua; Brendan C Visser; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2016-07-21       Impact factor: 3.647

7.  Association between intraoperative hypotension and postoperative myocardial injury in patients with prior coronary stents undergoing high-risk surgery: a retrospective study.

Authors:  Sang Hyun Lee; Jie Ae Kim; BurnYoung Heo; Young Ri Kim; Hyun Joo Ahn; Mikyung Yang; Jaeni Jang; Soohyun Ahn
Journal:  J Anesth       Date:  2020-01-21       Impact factor: 2.078

8.  Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Maurizio Giuseppe Abrignani; Marco Ambrosetti; Nadia Aspromonte; Gabriella Barile; Roberto Caporale; Giancarlo Casolo; Emilia Chiuini; Andrea Di Lenarda; Pompilio Faggiano; Domenico Gabrielli; Giovanna Geraci; Alessio Gaetano La Manna; Aldo Pietro Maggioni; Alfredo Marchese; Ferdinando Maria Massari; Gian Francesco Mureddu; Giuseppe Musumeci; Federico Nardi; Antonio Vittorio Panno; Roberto Franco Enrico Pedretti; Massimo Piredda; Enrico Pusineri; Carmine Riccio; Roberta Rossini; Fortunato Scotto di Uccio; Stefano Urbinati; Ferdinando Varbella; Giovanni Battista Zito; Leonardo De Luca
Journal:  Eur Heart J Suppl       Date:  2018-05-31       Impact factor: 1.803

9.  Non-cardiac surgery following drug-eluting coronary stent implantation-a question of timing?

Authors:  Andrew J Mitchell; Michael A Gillies; Nicholas L Cruden
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

10.  Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.

Authors:  Sean van Diepen; Pierluigi Tricoci; Mohua Podder; Cynthia M Westerhout; Philip E Aylward; Claes Held; Frans Van de Werf; John Strony; Lars Wallentin; David J Moliterno; Harvey D White; Kenneth W Mahaffey; Robert A Harrington; Paul W Armstrong
Journal:  J Am Heart Assoc       Date:  2015-12-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.